Shree Ganesh Biotech (India) share news, announcements and annual reports
BSE: 539470Pharmaceuticals & BiotechnologySmall Cap
Shree Ganesh Biotech (India) Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2015
Last close ₹0.43down ₹0.04 (8.51%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.47.
30 Oct: open ₹0.46, high ₹0.47, low ₹0.40
52-week range of traded prices to 30 Oct 2026
₹0.40Low, 30 Oct 2026₹0.75High, 30 Oct 2025
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17 Cr3,998th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 12,70,916
Shree Ganesh Biotech (India) share news and announcements
460 announcements, routine notices left out, newest first. Page 10 of 10.
Apr 2016
13 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mar 2016
Feb 2016
23 Feb · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
Jan 2016
12 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Dec 2015
24 Dec · Authorised KMPs to determine materiality of events/information
Nov 2015
24 Nov · Shareholding Pattern for September 30, 2015
24 Nov · Listing of equity shares of Shree Ganesh Biotech (India) Ltd
Trading Members of the Exchange are hereby informed that effective from November 24, 2015, the equity shares of Shree Ganesh Biotech (India) Ltd (Scrip Code: 539470) are listed and admitted ....